Gut feeling: identifying those at risk of coeliac disease
New CDRC learning module focuses on at-risk patient groups
The Coeliac Disease Resource Centre (CDRC), supported by Glutafin, has launched the second in a series of five learning modules for healthcare professionals. This module focuses on patient groups at risk of coeliac disease and gives an insight into which groups of patients to consider, including first-degree relatives and those with associated conditions, such as type 1 diabetes mellitus, autoimmune thyroid disease, autoimmune liver disease, Addison's disease, osteoporosis, anaemia, irritable bowel syndrome, infertility problems, lactose intolerance, neurological disorders and associated chromosomal disorders.
The second module, like the first, has been approved by the British Dietetic Association (BDA) for four learning hours.
The modules aim to support clinical practice and increase awareness of relevant topic areas in the diagnosis and management of patients with coeliac disease. They can be utilised by individuals for continuing professional development (CPD) purposes.
Each module focuses on evidence-based learning with a series of directed learning activities, reflective practice exercises and a case study to complete.
The first module in the series, focusing on the underdiagnosis of coeliac disease, was launched in the Autumn of 2006 and has proved to be a popular learning tool with healthcare professionals.
To receive further information or a copy of the first and/or second module healthcare professionals should contact the CDRC, supported by Glutafin, by calling 01225 711566 or emailing email@example.com